Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 122 | 8,127 | 0 | 0 | 13,819 |
| Gross Profit | 122 | 8,127 | N/A | N/A | 13,819 |
| Operating Expenses | 127,611 | 128,066 | 124,567 | 102,487 | 92,457 |
| Operating Income | -127,489 | -119,939 | -124,567 | -102,487 | -78,638 |
| Interest Expense | 10,962 | 10,929 | 10,754 | 4,010 | 3,040 |
| Other Income | 3,426 | 701 | -893 | 2,415 | -2,473 |
| Pre-tax Income | -135,025 | -130,167 | -136,214 | -104,082 | -84,151 |
| Net Income Continuous | -135,025 | -130,167 | -136,214 | -104,082 | -84,151 |
| Minority Interests | -15,044 | -14,308 | -15,180 | -12,232 | -10,693 |
| Net Income | $-119,981 | $-115,859 | $-121,034 | $-91,850 | $-73,458 |
| EPS Basic Total Ops | -1.01 | -0.98 | -1.03 | -0.78 | -0.60 |
| EPS Basic Continuous Ops | -1.13 | -1.10 | -1.16 | -0.88 | -0.68 |
| EPS Diluted Total Ops | -1.01 | -0.98 | -1.03 | -0.78 | -0.60 |
| EPS Diluted Continuous Ops | -1.13 | -1.10 | -1.16 | -0.88 | -0.68 |
| EBITDA(a) | $-127,054 | $-120,954 | $-123,072 | $-101,946 | $-78,638 |